2-n-Heptyl-4-hydroxyquinoline N-oxide is an inhibitor of electron transfer through the cytochrome bc1 segment of the respiratory chain. In addition, this compound has long been known to act as an uncoupling agent when added at high concentrations (Slater, 1967) . More recently, the latter property of this antibiotic has become a central issue of controversy in the discussion of proton translocation linked to oxidation of ferrocyanide by antimycin-inhibited mitochondria (Papa et al., 1977; Wikstrom, 1977 Wikstrom, , 1978 Lorusso et al., 1979 ).
Papa and co-workers reported that this proton translocation is sensitive to high concentrations of the inhibitor (Papa et al., 1977; Lorusso et al., 1979) , and claim that this inhibitory effect is not correlated with an increase in the proton conductance of the mitochondrial membrane as suggested by Wikstr6m (1978) . Instead, they concluded that the observed proton translocation linked to oxidation of ferrocyanide is due to antimycininsensitive electron transfer in the cytochrome bc1 segment, which is blocked by high concentrations of 2-n-heptyl-4-hydroxyquinoline N-oxide. Lorusso et al. (1979) measured the effect of this antibiotic on proton conduction through mitochondrial membranes in a system where uptake of H+ into the mitochondria was driven by an electrical membrane potential. 
Experimental and Results
Preparation of mitochondria and measurements of mitochondrial protein and of pH were carried out as described previously (Krab & Wikstr6m, 1979) .
pH-jump experiments were performed essentially as described by Mitchell & Moyle (1967) . Fig. 1 shows that, in the absence of 2-n-heptyl-4-hydroxyquinoline N-oxide (trace a), addition of HCI to the anaerobic mitochondrial suspension results in a fast pH change, the extent of which is determined by the external buffering power of medium and mitochondria. This is followed by a slow decay towards a more alkaline p11, which is due to equilibration of protons across the mitochondrial membrane. The final pH value is determined by the total buffering power, including that of the inside (matrix) phase (cf. Mitchell & Moyle, 1967) .
In the presence of increasing amounts of 2-n-heptyl-4-hydroxyquinoline N-oxide the decay phase in the alkaline direction is accelerated (trace In parallel experiments (not shown) we confirmed the report by Lorusso et al. (1979) that net H+ translocation linked to ferrocyanide oxidation is indeed abolished by 2-n-heptyl-4-hydroxyquinoline N-oxide in the concentration range 3-10nmol/mg of mitochondrial protein. This is precisely the range in which the antibiotic accelerates H+ uptake driven by ApH to a point that is indistinguishable from the effect of an uncoupling agent (cf. Fig. 1 ). It should also be noted that the amount of antibiotic added to reach these effects is of the same order of magnitude as the observed net proton translocation in the absence of antibiotic (see Lorusso et al., 1979 Fig. 1 . Stimulation of ApH-driven proton uptake by 2-n-heptyl-4-hydroxyquinoline N-oxide in rat liver mitochondria A medium containing 150mM-KCI, 1 mM-Hepes [4-(2-hydroxyethyl)-1 -piperazine-ethanesulphonatel and 0.68,g of valinomycin/ml, pH 7.2, at 250C was made anaerobic by bubbling with ultrapure argon (containing less than 3 p.p.m. of 02), and then anaerobic rat liver mitochondria (6.2mg of protein/ml) were added. The experiments were carried out anaerobically under a stream of argon in a glass vessel that was sealed except for a narrow port for additions. After 20min of equilibration, 150n-equiv. of HCI was added as indicated (as 5 ,1 of an anaerobic 30 mM-HCI solution). In trace (a) no further additions were made. In traces (b) and (c) 3 and 6 nmol of 2-n-heptyl-4-hydroxyquinoline Noxide were present respectively. Trace (d) was obtained in the presence of 0.33 ,uM-carbonyl cyanide p-trifluoromethoxyphenylhydrazone. The incubation volume was 3 ml. The four traces represent different incubations with the same batch of rat liver mitochondria. Several experiments of the kind shown ensured that there was no time-dependent change of the mitochondria with respect to the measured parameters. Identical results were also obtained in experiments where the conditions corresponding to (a)-(d) were achieved by subsequent additions to the same incubation, or where the entire experiment was performed aerobically in the presence of rotenone.
Discussion
Our experiments show that, when 2-n-heptyl-4-hydroxyquinoline N-oxide is present in sufficiently high concentrations, it catalyses ApH-driven H+ uptake into mitochondria. This suggests a mechanism in which the antibiotic acts in a similar way to weak permeant acids (e.g. Pi or acetate). Protons are picked up by the anionic form of the compound on the outside of the membrane, transferred across the membrane as the uncharged acid, and this is followed by proton release on the inside in an overall process driven exclusively by ApH. Catalysis of membrane-potential-driven H+ flux by this antibiotic appears to be much less efficient as judged from experiments similar to those in Fig. 1 , but without valinomycin (and see Wikstrom, 1978; Lorusso et al., 1979) . This may be due to a much smaller mobility of the charged form of the compound in the membrane as compared with that of the uncharged acid.
The presently discussed effect of the antibiotic requires much higher concentrations than those that inhibit electron transfer in the cytochrome bc1 segment (0.17nmol/mg of protein; Slater, 1967) . However, at high concentrations 2-n-heptyl-4-hydroxyquinoline N-oxide will function as an effective uncoupling agent provided that the membrane potential is collapsed, e.g. by K+ plus valinomycin. Since these are exactly the conditions in which H+ translocation linked to ferrocyanide oxidation is studied, we conclude that the inhibition of net proton translocation by the antibiotic observed by Lorusso et al. (1979) is due to uncoupling. Since these authors only tested the antibiotic for membranepotential-induced H+ translocation, they did not detect the particular type of uncoupling shown in the present work.
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